MycoBiomDB – Record Details (MyCo_2167)

Biomarker Record Details

Database ID: MyCo_2167
DB IDMyCo_2167
TitleNeonatal T cells in an adult lung environment are competent to resolve Pneumocystis carinii pneumonia
Year2001
PMID11313412
Fungal Diseases involvedPneumocystis carinii pneumonia
Associated Medical ConditionNone
GenusPneumocystis
Speciescarinii
OrganismPneumocystis carinii
Ethical StatementNone
Site of InfectionNone
Opportunistic invasiveOpportunistic
Sample typeBiopsy
Sample sourceExtracted cell supernatant
Host GroupAnimal
Host Common nameMice
Host Scientific nameMus musculus
Biomarker NameTNF-α
Biomarker Full NameTumor Necrosis Factor alpha
Biomarker TypeDiagnostic
BiomoleculeProtein
Geographical LocationUSA
CohortFive- to 6-wk-old BALB/c SCID and BALB/c mice were purchased from the National Cancer Institute (NCI). Mice were maintained at the Veteri-nary Medical Unit (VMU) of the Veterans Administration Medical Center (VAMC) under pathogen-free conditions.
Cohort No.None
Age GroupNone
P ValueNone
SensitivityNone
SpecificityNone
Positive Predictive ValueNone
MICNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismPneumocystis carinii is an opportunistic fungal pathogen that affects predominantly immunocompromised hosts in- cluding those with AIDS. P. carinii pneumonia (PCP)3 remains the most frequently reported serious opportunistic infec- tion in AIDS patients and the second highest cause of mortality among persons with AIDS in the U.S., despite the availability of effective chemoprophylaxis. Primary P. carinii infection is not common because immunocompetent individuals develop Ab to P. carinii by 2–3 years of age. Recently, it has been reported that there is a relatively high incidence of P. carinii infection in au-topsy specimens of children who die from sudden infant death syndrome. Although this does not necessarily indicate that PCP is a factor in sudden infant death syndrome it may reflect the fact that children frequently carry subclinical P. carinii infection. How- ever, very young patients with AIDS suffer a more fulminate course of PCP than older children with AIDS.
TechniqueELISA
Analysis MethodELISA Based
ELISA kitssandwich ELISA kit (PharMingen), Ribo-Quant in vitro transcription and RPA kits (PharMingen)
Assay DataNone
Validation Techniques usedELISA
Up Regulation Down RegulationDecrease
Sequence DataNone
External LinkNone